What guidance did Bio-key International's management provide for the next earnings period?

What is Bio-key International's gross profit margin?

What were the key takeaways from Bio-key International's earnings call?

What does Bio-key International do and what are its main business segments?

What is Bio-key International's latest dividend and current dividend yield?

What is the market's earnings forecast for Bio-key International next quarter?

Did Bio-key International beat or miss consensus estimates last quarter?

What were the key takeaways from Bio-key International’s earnings call?

- **Revenue decline explained**: Q3 2025 down 38% YoY due to delayed defense and banking orders, but ARR remains stable at $6-7M.
- **Margin resilience**: Gross margin held steady at 77%, with 8% YoY expense reduction.
- **Defense growth engine**: Two top defense agencies now using BIO-key, with pipeline expansion via partner network.
- **Funding boost**: $3M post-quarter capital infusion strengthens liquidity for 2026 growth initiatives.
- **Key 2026 catalysts**: Banking customer renewal ($1-3M), Egypt bank CIAM deployment, and PortalGuard 7 launch (Q2 2026).

**【CEO Summary Section】**
- Q3 2025 revenue of $1.55 million reflects a $595,000 YoY decline due to delayed large orders, including a $140,000 defense contract pushed to Q4.
- Annual recurring revenue (ARR) is estimated at $6-7 million, with a 90%+ renewal rate and single-digit churn.
- New EcoID 3 fingerprint scanner launched, with initial orders of ~7,500 units to defense customers.
- Defense sector growth driven by cyber resiliency needs, with two top global defense agencies now using BIO-key solutions.
- $3 million post-quarter funding via warrant exercise enhances liquidity and growth capacity.

**【CFO Financial Commentary】**
- Q3 2025 GAAP net loss of $965,000 (-$0.15/share) vs. $739,000 (-$0.39/share) in Q3 2024, despite 8% YoY operating expense reduction to $2.1 million.
- Gross margin remained strong at 77%, supported by high-margin software solutions.
- $2 million cash on hand as of Q3, with $3.7 million in current assets post-quarter funding.

**【Q&A Highlights】**
- National Bank of Egypt deployment expected to expand to customer-facing use cases in 2026, following employee base rollout.
- Defense contracts show long-term potential, with one unnamed Middle East deployment exceeding prior multi-million dollar wins.
- EcoID 3 priced at $49.99 (vs. $69-70 for legacy PIV Pro) with enhanced security features, targeting regulated industries.
- CEO confident in 2026 break-even trajectory, citing pipeline strength and partner network expansion.
- Stock volatility attributed to market interest in security sector and BIO-key's unique biometric IAM offering.

BIO-key International, Inc. (BKYI) Q3 2025 Earnings Call Transcript

- **Revenue Surge**: 49% YoY growth driven by defense contracts and hardware sales, despite margin pressure.
- **Cost Control**: 13.5% SG&A reduction offset by R&D, with expenses expected to stabilize.
- **Strategic Wins**: Secured multiyear defense deals in EMEA, leveraging EU's €150B cybersecurity funding.
- **Cash Flow Focus**: Liquidating legacy inventory to improve liquidity and gross margins.
- **Market Expansion**: Targeting enterprise banking in Africa and rebuilding North American public sector sales.

**【CEO Summary Section】**
- Q2 2025 revenue rose 49% YoY to $1.7 million, driven by hardware sales (+$458k) and defense contracts.
- SG&A expenses reduced 13.5% YoY, offset by R&D investments for next-gen products like PortalGuard.
- Secured major deployments: National Bank of Mozambique, Middle East police force (3-year PortalGuard), and $600k follow-on orders for a defense ministry (totaling €3M over 4 years).
- EU defense spending surge (5% GDP by 2035, 1.5% for cybersecurity) creates growth opportunities in biometric IAM solutions.
- Shifting focus to BIO-key-branded solutions in EMEA, with improving pipeline and gross margins.
- Rebuilding North American sales with in-office model and new leadership to drive public sector growth.

**【CFO Financial Commentary】**
- Q2 gross profit $1.2M (+40% YoY), but margin declined to 73% vs. 77% due to lower-margin hardware sales.
- License fee revenue +4%, service revenue +11%, reflecting subscription growth and customer upgrades.
- Cash increased to $2.3M (from $438k YoE), with accounts receivable up 37% YoY.
- Note payable reduced to $447k from $1.5M, improving liquidity.

**【Q&A Key Highlights】**
- **Expense Trends**: Q2 had a $300k blip in costs, but expect to maintain reduced SG&A run rate in H2.
- **Defense Contracts**: Multiple undisclosed contracts already generating Q3 revenue, with multiyear EU defense funding (€150B SAFE mechanism) supporting long-term growth.
- **Inventory Sales**: Selling legacy hardware inventory, aiming to clear bulk by year-end for cash flow.
- **Africa Update**: Focused on enterprise banking deals (e.g., Bank of Mozambique), with pipeline for additional financial sector contracts.
- **Hardware/Software Mix**: Typically sold together, with defense customers adding touchpoints (e.g., 40k scanners deployed for a ministry).


BIO-key International, Inc. (BKYI) Q2 2025 Earnings Conference Call Transcript

- **Revenue Resilience**: Q1 up 10% to $1.6M, despite $1.2M legacy contract loss. Key customer upgrade to $3M two-year deal (Q1 '26 start) offsets short-term pain.
- **Margin Strength**: 83% gross margin, 23% SG&A reduction, and $3.1M cash boost from warrant exercise highlight financial discipline.
- **Growth Catalysts**: EMEA defense deals, California phone-free schools regulation compliance, and Passkey:YOU biometric adoption in restricted environments.
- **Risk Mitigation**: Diversified education contracts (e.g., 20K Wyoming users) and deferred revenue growth (50% YoY) provide stability.
- **Debt Management**: Reduced debt by 50% to $762K, with no immediate funding needs despite Q1 cash burn of $1.2M.


**【CEO Opening Remarks】**
- Q1 2025 revenue rose 10% to $1.6 million, driven by high-margin BIO-key branded products in EMEA. Year-over-year decline of $1.2 million due to a legacy financial services contract termination.
- Key customer upgraded to a fingerprint-only biometric solution, generating $690,000 in Q1 and expected to double to $3 million over the next two years (Q1 '26 start).
- Gross margin remained strong at 83%, with SG&A expenses reduced by 23% YoY. Cash position increased to $3.1 million, with debt reduced by 50% to $762,000.
- New deployments in education (e.g., Wyoming DOE, 20,000 users) and defense sectors highlight growth opportunities. California EdTech JPA partnership positions BIO-key for phone-free school regulations.

**【CFO Financial Overview】**
- Q1 '25 revenue: $1.6 million (down 24% YoY due to legacy contract termination). Service revenue up 27% to $273,000, hardware revenue up 1,200% to $236,000.
- Gross profit: $1.3 million (82.6% margin), down 32% YoY due to lower revenue and hardware mix. Operating expenses reduced 18% to $2 million.
- Net loss: $737,000 (-$0.16/share), wider than Q1 '24 ($573,000 loss) due to share dilution from warrant exercises.
- Cash inflow from $3.8 million warrant exercise offset by $1.2 million in operating cash burn. Deferred revenue up 50% to $2.4 million from multi-year contracts.

**【Q&A Key Highlights】**
- **Customer Concentration**: Largest customer now accounts for ~40% of revenue, with a $3 million two-year renewal expected in Q1 '26. Other education and defense contracts diversify risk.
- **EMEA Growth**: Transitioning away from low-margin Swivel Secure services, focusing on BIO-key solutions with 82%+ gross margins. Defense ministry deals in Europe and Middle East represent new high-margin opportunities.
- **Passkey:YOU Adoption**: Biometric Passkey solution gaining traction in manufacturing and call centers where phones are banned. Unique value as a FIDO authenticator without mobile dependency.
- **Cash Position**: $3.1 million cash on hand, with no immediate funding needs. Debt reduction and warrant proceeds provide runway for growth.
- **Seasonality**: Q3 may face EMEA summer slowdown, but Q2+ sequential growth expected from education renewals and defense deals.
- **Inventory Management**: Aggressively liquidating legacy hardware inventory, with $1.2 million in fingerprint scanners sold in Q1.


BIO-key International, Inc. (BKYI) Q1 2025 Earnings Call Transcript

- **Strategic Shift Payoff**: 20% YoY license fee growth and 77% gross margin highlight success of exiting low-margin business.
- **Financial Resilience**: Debt reduction to $730K and 23% cash burn decline position for 2025 growth.
- **Major Wins**: $910K financial services contract and defense ministry expansion (potential tripling in 3 years) drive confidence.
- **2025 Momentum**: Q1 license revenue up YoY, with hardware and services poised for growth; AWS launch accelerates partner-driven expansion.
- **R&D Edge**: Biometric integrations and mobile authentication investments set up long-term competitive advantage.


**【CEO Opening Remarks】**
- **Strategic Transition Success**: Exited low-margin Swivel Secure business, focusing on core BIO-key solutions, leading to 20% YoY growth in high-margin software license fees ($5.2M) and adjusted gross margin improvement from 64% to 77%.
- **Financial Strength**: Reduced debt to $730K (from $1.5M) and raised $3.8M via warrant exercises. 2024 cash burn decreased 23% to $2.9M.
- **Customer Expansion**: Secured $910K contract with a financial services client and expanded defense ministry deployment (30,000+ personnel), with potential tripling in the next 3 years.
- **Market Momentum**: Seeing strong order activity in 2025, particularly in Europe, defense, and education sectors. Launched PortalGuard on AWS Marketplace, with 50% of new business via partners.

**【CFO Financial Overview】**
- **Revenue Performance**: Total revenue $6.9M (-11% YoY), driven by 20% license fee growth offset by Swivel Secure exit. Q4 revenue $1.5M (-17% YoY) due to hardware order timing.
- **Profitability**: Gross profit $5.6M (+294% YoY), net loss narrowed to $4.3M (-50% YoY). Q4 net loss $1.6M (-33% YoY).
- **Balance Sheet**: $1.9M current assets, $438K cash. Hardware reserves reduced by $213K in Q4.

**【Q&A Highlights】**
- **2025 Outlook**: Expect revenue growth and profitability, with breakeven near term. Q1 2025 license revenue up YoY, hardware and services poised for growth.
- **Contract Details**: $910K contract split between Q4 ($250K) and Q1 ($600K). Defense ministry deal could expand to millions in future years.
- **R&D Focus**: Investing in biometric integrations, mobile authentication, and API partnerships to enhance user experience and security.
- **Risk Management**: Monitoring Nigeria ID program but diversifying hardware sales to other markets.
- **Expense Control**: Flat OpEx expected in near term, with focus on cost efficiency.


BKYI

BKYI fundamentals

Earnings Call

You can ask Aime